The Virginia Center for Allergy & Asthma - NIH Asthma Update 2007

NIH Asthma Update 2007
Key Differences from 2002 Report

Initial Assessment – Classify severity to initiate control
Frequent Monitoring – Assess control on an ongoing basis and adjust therapy as necessary
Severity – The intrinsic intensity of the disease process (ideally measured at initial presentation)
Control – The degree to which the manifestations of asthma are minimized and goals of therapy are met
Both severity and control have 2 domains:
Impairment – frequency and intensity of symptoms and functional limitations the patient is experiencing
Risk – likelihood of either asthma exacerbations, progressive decline in lung function or risk of adverse events

    Goals of Asthma Control:

  • Reduce impairment:
  • Prevent chronic symptoms
  • Require infrequent use of inhaled SABA (less than 1x/wk)
  • Maintain “normal” pulmonary function
  • Maintain normal activity levels
  • Meet patients’ and families’ expectations of asthma care

    Reduce risk:

  • Prevent recurrent exacerbations and minimize need for ED visits
  • Prevent progressive loss of lung function
  • Provide optimal pharmacotherapy with minimal or no adverse side effects
  • Periodic assessments (every 1-6 months) and ongoing monitoring of asthma control